These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22659241)

  • 1. Nanomedicine applications towards the cure of HIV.
    Lisziewicz J; Tőke ER
    Nanomedicine; 2013 Jan; 9(1):28-38. PubMed ID: 22659241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding a cure for HIV: will it ever be achievable?
    Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
    J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanochemistry-based immunotherapy for HIV-1.
    Lori F; Calarota SA; Lisziewicz J
    Curr Med Chem; 2007; 14(18):1911-9. PubMed ID: 17691933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
    Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
    J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of finding a cure for HIV infection.
    Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
    Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
    Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the viral reservoir of latently infected CD4(+) T cells be eradicated with antiretroviral HIV drugs?
    Smith RJ; Aggarwala BD
    J Math Biol; 2009 Nov; 59(5):697-715. PubMed ID: 19165438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.
    Rodriguez B; Asmuth DM; Matining RM; Spritzler J; Jacobson JM; Mailliard RB; Li XD; Martinez AI; Tenorio AR; Lori F; Lisziewicz J; Yesmin S; Rinaldo CR; Pollard RB
    J Acquir Immune Defic Syndr; 2013 Dec; 64(4):351-9. PubMed ID: 24169120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking replication-competent HIV reservoirs in infected individuals.
    Chun TW
    Curr Opin HIV AIDS; 2013 Mar; 8(2):111-6. PubMed ID: 23380652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
    Noel N; Peña R; David A; Avettand-Fenoel V; Erkizia I; Jimenez E; Lecuroux C; Rouzioux C; Boufassa F; Pancino G; Venet A; Van Lint C; Martinez-Picado J; Lambotte O; Sáez-Cirión A; Prado JG
    J Virol; 2016 Jul; 90(13):6148-6158. PubMed ID: 27122576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Combination Antiretroviral Therapy Limits HIV-1 Persistence in Children.
    Luzuriaga K
    Annu Rev Med; 2016; 67():201-13. PubMed ID: 26768239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
    Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
    mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Active HIV-1 Infection in CD34
    Latinovic OS; Neal LM; Tagaya Y; Heredia A; Medina-Moreno S; Zapata JC; Reitz M; Bryant J; Redfield RR
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):718-728. PubMed ID: 31099257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.
    Katlama C; Deeks SG; Autran B; Martinez-Picado J; van Lunzen J; Rouzioux C; Miller M; Vella S; Schmitz JE; Ahlers J; Richman DD; Sekaly RP
    Lancet; 2013 Jun; 381(9883):2109-17. PubMed ID: 23541541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
    Shan L; Siliciano RF
    Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.